£108.91

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Price data last checked 10 day(s) ago - will refresh soon

View at Amazon

Price History & Forecast

Last 81 days • 81 data points (No recent data available)

Historical
Generating forecast...
£113.09 £108.49 £109.50 £110.50 £111.50 £112.50 £113.51 30 January 2026 19 February 2026 11 March 2026 31 March 2026 20 April 2026

Price Distribution

Price distribution over 81 days • 2 price levels

Days at Price
Current Price
64 days · current 17 days 0 16 32 48 64 £109 £113 Days at Price

Price Analysis

Most common price: £109 (64 days, 79.0%)

Price range: £109 - £113

Price levels: 2 different prices over 81 days

Description

Explore the radical transformation in cancer care with this comprehensive guide on novel technologies and personalized medicine. As the field shifts toward treatments that augment the immune response to tumors, understanding the latest breakthroughs is essential for medical professionals. This text examines the most advanced developments in immune therapeutics, focusing on how these methods target tumor cells. It provides in-depth coverage of immune checkpoint inhibitors, which represent some of the most significant advancements in the industry. You will learn about approved antibody drugs directed at cell surface proteins such as CTLA4 and PD-1. These therapies are now considered foundational treatments for several solid tumor indications. This book serves as a vital resource for those studying the drug development and clinical application of modern immunotherapy. Stay informed on the technologies driving the future of oncology and the evolution of cancer treatment strategies.

Key Features

Covers the shift toward personalized medicine and new technologies in cancer care.

Provides detailed information on therapeutics that augment the immune response to tumors.

Analyzes immune checkpoint inhibitors as highly advanced examples of immune therapeutics.

Explains the application of approved antibody drugs targeting CTLA4 and PD-1 proteins.

Examines the role of foundational treatments for various solid tumor indications.

Focuses on the drug development process and clinical application of modern immunotherapy.

Product Specifications

Barcode

No barcode data available